Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Weinstein

Showing results (481-490 of 505) with videos related to

Pageof 51
Sort By:
Cancer Research|July 20, 2006
Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinomaJoseph Riss, Chand Khanna, Seongjoon Koo, et al.
Cancer Discovery|April 27, 2013
Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic driversCurtis R Pickering, Jiexin Zhang, Suk Young Yoo, et al.
Nature Communications|May 30, 2014
A pan-cancer proteomic perspective on The Cancer Genome AtlasRehan Akbani, Patrick Kwok Shing Ng, Henrica M J Werner, et al.
Plos One|April 22, 2016
Mutational Profiles Reveal an Aberrant TGF-β-CEA Regulated Pathway in Colon AdenomasJian Chen, Gottumukkala S Raju, Wilma Jogunoori, et al.
Nature Genetics|May 10, 2016
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomasJoshua D Campbell, Anton Alexandrov, Jaegil Kim, et al.
Science (New York, N.Y.)|July 30, 2011
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1Nishant Agrawal, Mitchell J Frederick, Curtis R Pickering, et al.
Cell|August 12, 2014
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of originKatherine A Hoadley, Christina Yau, Denise M Wolf, et al.
Cancer Discovery|June 13, 2015
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilitiesFerdinandos Skoulidis, Lauren A Byers, Lixia Diao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2012
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistanceLauren Averett Byers, Lixia Diao, Jing Wang, et al.
Cell Reports|April 5, 2018
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome AtlasTheo A Knijnenburg, Linghua Wang, Michael T Zimmermann, et al.
Pageof 51

Showing results (481-490 of 505) with videos related to

Sort By:
Pageof 51
Cancer Research|July 20, 2006
Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinomaJoseph Riss, Chand Khanna, Seongjoon Koo, et al.
Cancer Discovery|April 27, 2013
Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic driversCurtis R Pickering, Jiexin Zhang, Suk Young Yoo, et al.
Nature Communications|May 30, 2014
A pan-cancer proteomic perspective on The Cancer Genome AtlasRehan Akbani, Patrick Kwok Shing Ng, Henrica M J Werner, et al.
Plos One|April 22, 2016
Mutational Profiles Reveal an Aberrant TGF-β-CEA Regulated Pathway in Colon AdenomasJian Chen, Gottumukkala S Raju, Wilma Jogunoori, et al.
Nature Genetics|May 10, 2016
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomasJoshua D Campbell, Anton Alexandrov, Jaegil Kim, et al.
Science (New York, N.Y.)|July 30, 2011
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1Nishant Agrawal, Mitchell J Frederick, Curtis R Pickering, et al.
Cell|August 12, 2014
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of originKatherine A Hoadley, Christina Yau, Denise M Wolf, et al.
Cancer Discovery|June 13, 2015
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilitiesFerdinandos Skoulidis, Lauren A Byers, Lixia Diao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2012
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistanceLauren Averett Byers, Lixia Diao, Jing Wang, et al.
Cell Reports|April 5, 2018
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome AtlasTheo A Knijnenburg, Linghua Wang, Michael T Zimmermann, et al.
Pageof 51